Crosstree’s Post

The October 2024 edition of our Pharma Services: Drug Development BlueBook is now available. Read why C-suite executives and private equity professionals in the health sciences industries turn to our publication for valuation trends, M&A activity, and transaction reporting. Here's a glimpse into the October 2024 edition: 📌Integrated Clinical Trial Services was acquired by Exima Research Network 📌Synexa Life Sciences announced its acquisition of Alderley Analytical 📌Healthie closed a $23MM Series A Financing, led by Birchmere Investments, TCMI, Watershed Capital, and VSV Management Download the full October edition now: https://hubs.li/Q02-9f1z0 #Insights #MergersAndAcquisitions #PrivateEquity #FinancialNews

Is this just the beginning for a new generation of biotech consolidators? In Q2, Genmab and Ono Pharmaceutical made their first acquisitions. Vertex inked its largest M&A deal since its founding. Incyte went back to the acquisition well after a brief period on the sidelines. Biogen quickly returned to shopping mode after having just digested its first acquisition in four years. Asahi Kasei forged a biotech consummation for the first time since 2019. “These emerging consolidators are sitting on meaningful cash reserves (average pro forma adjusted cash of $3.8 billion), thus paving the way for further M&A and/or stock buybacks as these companies face shareholder pressure to deploy this capital (e.g. Incyte’s $2.0 billion buyback in May 2024),” William Blair healthcare bankers wrote in their quarterly industry update. #biotech #pharma #mergersandacquisitions #consolidation #manda

We are “back to the future” by reconciling the highest level of analytical data to the “big picture” of metabolism. By a slight intervention on the binding of a single enzyme to its wrong anchor we reshape the metabolic picture.

When it comes to M&A in the pharma industry, integrating companies efficiently is a difficult task. That's why well-organized data is crucial, both from a value standpoint and a regulatory perspective. Learn about why this means the industry's tech sector and clinical software companies can make acquisitions easier to close: https://hubs.la/Q02vkbhF0 #M&A #Biotech

#GenerationHealthSpeaks with Guillermo on the changing landscape of biotech IPOs, especially in the US. Once a common route for funding, IPOs and SPACs have become rare in recent years. As the market slowly recovers, companies are finding new ways to secure funding, particularly by bringing pharmaceutical companies into the development process earlier as true partners. Guillermo highlights how this approach is helping companies move forward and access the capital needed for critical trials, like phase three. Guillermo Tramontin is an Executive Search Specialist and Portfolio Builder for VCs at Cavenagh Health, helping VC-backed companies in life sciences, biopharma, medtech, and digital health build world-class leadership teams focused on real patient impact. What do you think? Drop your questions and thoughts in the comments below! Let’s continue the conversation. #GenerationHealthSpeaks #BiotechFunding #IPOChallenges #VCImpact #HealthcareInnovation #TheGenH

Pharma Partnering Summit taking place during 16th & 17th October 2024 in Boston, MA is one of the most prestigious in-person events for life science industry professionals. The aim of the summit is to help companies to expand their network, identify products, partners and investors. Register Now at: https://lnkd.in/ddYMF-GZ #investment #innovation #research #pharma #network #lifesciences #event #management #conference #businessdevelopment #startup #startups #venturecapital #privateequity #funding #partnerships #event #pharmaceutical #pharmaceuticalindustry #biotechnology #biotech #pharmaceuticalcompanies #biotechnologyindustry #venturecaptial #investements #clinicalresearch #clinicaltrial #drugdevelopment #drugdiscovery #iplaw #dealmaker #conference #summits #therapeutics #digitalhealth #bioinformatics #licensing #collaboration #mergersandacquisitions #fundings #research #pharmamarketing #startups #partnering #clinicaldevelopment #preclinical #drugdelivery #fdaapproval #speakers #delegates #sponsors #lifesciences

Ready to take your Business to the Next Level ? Join Digital Health Envision Summit to Learn more about the latest trends, Innovations, cutting Edge Technologies, industry practices, in partnering. Don't miss this exclusive event for Digital Health Professionals. #DigitalHealth2024 #investment #innovation #research #pharma #network #lifesciences #event #management #conference #businessdevelopment #startup #startups #venturecapital #privateequity #funding #partnerships #event #pharmaceutical #pharmaceuticalindustry #biotechnology #biotech #pharmaceuticalcompanies #biotechnologyindustry #venturecaptial #investements #clinicalresearch #clinicaltrial #drugdevelopment #drugdiscovery #iplaw #dealmaker #conference #summits #therapeutics #digitalhealth #bioinformatics #licensing #collaboration #mergersandacquisitions #fundings #research #pharmamarketing #startups #partnering #clinicaldevelopment #preclinical #drugdelivery #fdaapproval #speakers #delegates #sponsors #lifesciences #HealthcareInnovation #EnvisioningTheFuture

Ready to take your Business to the Next Level ? Join Digital Health Envision Summit to Learn more about the latest trends, Innovations, cutting Edge Technologies, industry practices, in partnering. Don't miss this exclusive event for Digital Health Professionals. #DigitalHealth2024 #investment #innovation #research #pharma #network #lifesciences #event #management #conference #businessdevelopment #startup #startups #venturecapital #privateequity #funding #partnerships #event #pharmaceutical #pharmaceuticalindustry #biotechnology #biotech #pharmaceuticalcompanies #biotechnologyindustry #venturecaptial #investements #clinicalresearch #clinicaltrial #drugdevelopment #drugdiscovery #iplaw #dealmaker #conference #summits #therapeutics #digitalhealth #bioinformatics #licensing #collaboration #mergersandacquisitions #fundings #research #pharmamarketing #startups #partnering #clinicaldevelopment #preclinical #drugdelivery #fdaapproval #speakers #delegates #sponsors #lifesciences #HealthcareInnovation #EnvisioningTheFuture